Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial-Reference-Cited by-同舟云学术

Preoperative gefitinib versus gefitinib and anastrozole in postmenopausal patients with oestrogen-receptor positive and epidermal-growth-factor-receptor-positive primary breast cancer: a double-blind placebo-controlled phase II randomised trial

Published:2005-06 Issue:6 Volume:6 Page:383-391
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Polychronis Andreas,Sinnett H Dudley,Hadjiminas Dimitri,Singhal Hemant,Mansi Janine L,Shivapatham Dharsha,Shousha Sami,Jiang Jie,Peston David,Barrett Nigel,Vigushin David,Morrison Ken,Beresford Emma,Ali Simak,Slade Martin J,Coombes R Charles

Publisher

Elsevier BV

Subject

Oncology

Reference48 articles.

1. Estrogen receptor alpha in human breast cancer: occurrence and significance;Ali;J Mammary Gland Biol Neoplasia,2000

2. First-line endocrine treatment of breast cancer: aromatase inhibitor or antioestrogen?;Wong;Br J Cancer,2004

3. Primary chemotherapy for breast cancer: the evidence and the future;Mano;Ann Oncol,2004

4. HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study;Arpino;Clin Cancer Res,2004

5. The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients;Klijn;Endocr Rev,1992

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MMSyn: A New Multimodal Deep Learning Framework for Enhanced Prediction of Synergistic Drug Combinations;Journal of Chemical Information and Modeling;2024-04-27

2. PRIMARY PREVENTION AND INTERCEPTION STUDIES IN RAS-MUTATED TUMOR MODELS EMPLOYING SMALL MOLECULES OR VACCINES;Cancer Prevention Research;2023-07-19

3. Traditional Chinese medicine for colorectal cancer treatment: potential targets and mechanisms of action;Chinese Medicine;2023-02-13

4. A novel cuproptosis-related prognostic 2-lncRNAs signature in breast cancer;Frontiers in Pharmacology;2023-01-09

5. Epidermal growth factor receptor (EGFR) expression in the serum of patients with triple-negative breast carcinoma: prognostic value of this biomarker;ecancermedicalscience;2022-07-20